They offer investors very different value propositions.

Now that the Abbott Freestyle Libre has received FDA clearance, Abbott and Dexcom will be forced into tight competition in the US market. On Dexcom’s third quarter call, CEO Kevin Sayer spent some ...

The factory-calibrated continuous glucose monitoring (CGM) system is being touted as less expensive, and a spokeswoman said it will not require bundling with a meter, which is required for a ...

The U.S. Centers for Medicare & Medicaid Services (CMS) has opted to cover the Freestyle Libre System from Abbott Laboratories for insulin-dependent diabetes patients. The system, which was just ...

The FDA has approved Abbott’s FreeStyle Libre Pro continuous glucose monitoring system for clinicians to use with diabetic patients. While Abbott markets a consumer version of the FreeStyle Libre in ...